USP starts field trials of FDA fake drug screening device

CD3 imageThe US Pharmacopeial Convention has started field testing a new low-cost screening device designed to detect counterfeit and poor quality medicines quickly. The handheld CD-3+ unit – originally developed by the US Food and Drug Administration (FDA) – uses multiple light sources to look at packaging using different wavelengths and provide images that can be interpreted by the user to differentiate between genuine and falsified medicines. The approach may also be applicable to individual tablets.

 

USP and the Center for Pharmaceutical Advancement and Training (CePAT)- which was launched last year to equip national and local regulatory authorities in Sub-Saharan Africa with the knowledge and skills to promote access to quality medicines – will carry out the field trials.

 

http://www.securingindustry.com/pharmaceuticals/usp-starts-field-trials-of-fda-fake-drug-screening-device/s40/a2056/#.U6PkGpSSzlI